Middle East & Africa Liver Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)
The liver cancer diagnostics market in Middle East & Africa is expected to grow from US$ 382.25 million in 2021 to US$ 575.86 million by 2028. It is estimated to grow at a CAGR of 6.0% from 2021 to 2028.
The early detection and monitoring of the tumor can provide a more effective treatment. Point-of-care (POC) testing allows the patient to have a handheld test that gives the results rapidly. Moreover, no expertise or special knowledge is required, which is vital when carried out in low-resource areas. Hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. Increased understanding of cancer biology and technological advances enabled the identification of many pathological, genetic, and molecular events that drive hepatocarcinogenesis, leading to the discovery of numerous potential biomarkers in this disease.
Some of the biomarkers used for liver cancer are Alpha-Fetoprotein (AFP), Glypican-3, Des-Gamma-Carboxy (Abnormal) Prothrombin (DCP), Gamma-Glutamyl Transferase, and Serum Alpha-1-Fucosidase, among others. A large number of biomarkers have been shown to have potential predictive significance. Hence, this factor will provide huge opportunities for the liver cancer diagnostics market during the projected period.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa Liver cancer diagnostics market at a substantial CAGR during the forecast period.
Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Liver Cancer Diagnostics Market Segmentation
The Middle East & Africa liver cancer diagnostics market is analyzed on the basis of type, end user, and country. Based on type, the market is segmented into laboratory tests, imaging, endoscopy, biopsy, and others. In 2021, the laboratory tests segment held the largest share of the market, and the imaging segment is expected to register a higher CAGR during the forecast period.
Based on laboratory tests, the market is segmented into blood tests and biomarkers. In 2021, the blood tests segment held a larger market share, and the same segment is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. In 2021, the hospitals and diagnostic laboratories segment held the largest share of the market, and the same segment is expected to register a higher CAGR during the forecast period.
Based on country, the Middle East & Africa liver cancer diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. In 2021, Saudi Arabia held the largest market share, and it is also expected to grow at the fastest CAGR during the forecast period.
Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; and Perspectum are the leading companies in the Middle East & Africa liver cancer diagnostics market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Liver Cancer Diagnostics Market – By Type
1.3.2 Middle East & Africa Liver Cancer Diagnostics Market – By End User
1.3.3 Middle East & Africa Liver Cancer Diagnostics Market – By Country
2. Middle East & Africa Liver Cancer Diagnostics Market Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Liver Cancer Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Liver Cancer Diagnostics Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Boosting Prevalence of Liver Cancer
5.2 Market Restraints
5.2.1 Expensive Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
5.3 Market Opportunities
5.3.1 Strengthening Demand for Point-of-Care Testing
5.4 Future Trends
5.4.1 Heighten Emergence of New Technologies
5.5 Impact Analysis
6. Middle East & Africa Liver Cancer Diagnostics Market Analysis
6.1 Middle East & Africa Liver Cancer Diagnostics Market Revenue Forecast and Analysis
7. Middle East & Africa Liver Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Blood Tests
7.3.2.1.1 Overview
7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Biomarkers
7.3.2.2.1 Overview
7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Endoscopy
7.4.1 Overview
7.4.2 Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging
7.5.1 Overview
7.5.2 Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Biopsy
7.6.1 Overview
7.6.2 Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Liver Cancer Diagnostics Market Analysis – By End User
8.1 Overview
8.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
8.3 Hospitals and Diagnostics Laboratories
8.3.1 Overview
8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institutes
8.4.1 Overview
8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 CRO Laboratories
8.5.1 Overview
8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Liver Cancer Diagnostics Market Country Analysis
9.1 Overview
9.1.1 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
9.1.1.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.1.3 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.1.1.1.3.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.1.1.1.4 UAE: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.2.3 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.1.1.2.4 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.1.1.2.5 Saudi Arabia: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.3.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.1.1.3.3.1 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.1.1.3.4 South Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4 Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.1.4.3 Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.1.1.4.3.1 Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.1.1.4.4 Rest of MEA: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Liver Cancer Diagnostics Market– Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 bioMerieux SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. HOFFMANN-LA ROCHE LTD.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Illumina, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Koninklijke Philips N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Siemens Healthineers AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 THERMO FISHER SCIENTIFIC INC.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GE Healthcare
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Perspectum
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 2. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 3. UAE: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 5. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 6. Saudi Arabia: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 7. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 8. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 9. South Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 11. Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 12. Rest of MEA: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments in the Liver Cancer Diagnostics Market
Table 14. Inorganic Developments in the Liver Cancer Diagnostics Market
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Liver Cancer Diagnostics Market Segmentation
Figure 2. Middle East & Africa Liver Cancer Diagnostics Market Segmentation, By Country
Figure 3. Middle East & Africa Liver Cancer Diagnostics Market Overview
Figure 4. Laboratory Tests Segment Held Largest Share by Type in Middle East & Africa Liver Cancer Diagnostics Market
Figure 5. Saudi Arabia Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East & Africa Liver Cancer Diagnostics Market, Industry Landscape
Figure 7. Middle East and Africa: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis of Drivers and Restraint Pertaining to Middle East & Africa Liver Cancer Diagnostics Market
Figure 10. Middle East & Africa Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028
Figure 11. Middle East & Africa Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 12. Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East & Africa Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
Figure 20. Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East & Africa Liver Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 24. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 25. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Rest of MEA: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- Abbott
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- Koninklijke Philips N.V.
- QIAGEN
- Siemens Healthineers AG
- THERMO FISHER SCIENTIFIC INC.
- GE Healthcare
- Perspectum
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa liver cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa liver cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the liver cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution